The Meeting for Advanced Synthetic Biology and Systems Bioengineering in Vancouver (MASSIV 1.0)

The Meeting for Advanced Synthetic Biology and Systems Bioengineering in Vancouver (MASSIV) 1.0 will bring together leading researchers, innovators, and trainees from around the world to discuss the future of synthetic biology and biomedical engineering.
Recent advances in genome, cell, tissue, and organ engineering have enabled us to push the boundaries of biology and medicine at an unprecedented scale. Hosted in Vancouver, MASSIV 1.0 will highlight cutting-edge technologies and applications at the interface of biology, engineering, regenerative medicine, and data science. We will place special emphasis on how long-standing synthetic biology and bioengineering principles, originally developed using microorganisms alongside computational and AI approaches, can now be applied to stem cell biology and tissue engineering to advance human health more than ever before.
The Japan Science and Technology Agency (JST) and Stem Cell Network (SCN) are pleased to be partnering to deliver this event, hosted by the School of Biomedical Engineering at UBC.

URL: https://www.massivconference.com/

Date: January 19 (Monday) – 22 (Tuesday), 2026

Venue: Vancouver British Columbia

Important Dates:
Abstract Submission closes: November 14, 2025 at 11:59pm PST
Abstract acceptance notification: November 17, 2025
Successful abstracts-conference registration closes: November 28, 2025 at 11:59pm PST

Keynote Speakers:
Prof. Patrick Yizhi Cai (Chair, Synthetic Genomics The University of Manchester)
Dr. Katie Galloway (Assistant Professor, Chemical Engineering Massachusetts Institute of Technology)
Prof. Hiroyuki Noji (Professor, Department of Bioengineering University of Tokyo)
Dr. Masayuki Su’etsugu (Professor, Department of Life Science Rikkyo University)
Dr. Asako Sugimoto (Professor, Graduate School of Life Science Tohoku University)
Dr. Sud Pinglay (Build Team Lead & Faculty SeaHub & The University of Washington)
Dr. Maryam Tabrizian (McGill University)
Dr. Brenda Andrews (The University of Toronto)